Results 251 to 260 of about 325,306 (358)

Surgical Outcomes of Lenvatinib Treatment Followed by Liver Resection for Advanced Hepatocellular Carcinoma Larger than 10 cm. [PDF]

open access: yesCancers (Basel)
Yokoo H   +8 more
europepmc   +1 more source

Synergistic Anti‐Cancer Therapy Through Ultrasound‐Induced Piezocatalytic Therapy and Tumor Treatment Fields

open access: yesAdvanced Science, EarlyView.
A novel, wearable anti‐cancer platform synergistically combines tumor treating fields (TTFs) and piezocatalytic therapy (PCT) via ultrasound‐activated, lead‐free piezocomposites. This strategy efficiently suppresses tumor growth, modulates the immune microenvironment, and demonstrates strong therapeutic synergy in both mouse model of subcutaneous tumor
Jing Jin   +9 more
wiley   +1 more source

Time to recurrence and BCLC stage at recurrence as critical variables in guiding treatment decisions for early-recurrent hepatocellular carcinoma after liver resection. [PDF]

open access: yesFront Oncol
Zhang JX   +17 more
europepmc   +1 more source

Significance of Diagnosis of Liver Metastases from Colorectal Cancer by Angio Helical CT and Intermittent Hepatic Arterial Infusion Chemotherapy after Hepatic Resection in Terms of Prognosis.

open access: bronze, 1997
Kazuo Hatsuse   +9 more
openalex   +2 more sources

Red Blood Cell‐Derived Exosomal miR‐93‐5p Promotes Lung Cancer Progression through PTEN Suppression

open access: yesAdvanced Science, EarlyView.
Red blood cell (RBC)‐derived exosomal miR‐93‐5p is elevated in lung cancer patients and correlates with poor outcomes. Exosomal miR‐93‐5p suppresses PTEN in cancer cells, enhancing proliferation, migration, and invasion. In mouse models, therapeutic inhibition with ASO‐miR‐93 5p reduces tumor growth, highlighting a bidirectional tumor‐RBC‐tumor axis ...
Ning Li   +4 more
wiley   +1 more source

Repeat hepatic resections for colorectal metastases to the liver

open access: bronze, 1995
WT Knoefel   +5 more
openalex   +1 more source

Partial resections of the liver [PDF]

open access: yes, 1977
Putnam, CW, Starzl, TE
core  

MnO2 Nanosponge‐Accelerated Cas12a Trans‐Cleavage: Breaking the Kinetic Barrier for In Vivo RNA Imaging

open access: yesAdvanced Science, EarlyView.
A Cas12a@MnO2 nanosponge (hMNS) nanoprobe is engineered to overcome the intracellular delivery and kinetic barrier of the conventional CRISPR/Cas12a system via GSH‐responsive release and Mn2⁺‐enhanced trans‐cleavage. It enables preamplification‐free detection of mRNA with single‐cell sensitivity, differentiation of mRNA expression between breast cancer
Wen‐jing Liu   +3 more
wiley   +1 more source

Determinants of Survival and Prognostic Factors in Patients Undergoing Liver Resection for Primary Hepatic Carcinoma-A Follow-Up Study. [PDF]

open access: yesClin Pract
Gurbadam U   +14 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy